Open access
Open access
Powered by Google Translator Translator

Cohort Study | Systemic or vaginal hormone therapy after early breast cancer.

24 Oct, 2022 | 14:00h | UTC

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study – JNCI: Journal of the National Cancer Institute

News Release: Hormone replacement therapy doesn’t lead to breast cancer reoccurrence – Oxford University Press

Commentaries:

Expert reaction to study looking at menopausal hormone therapy after early-stage breast cancer, and breast cancer recurrence – Science Media Centre

Hormone Replacement Therapy Won’t Raise Recurrence Rate for Breast Cancer Survivors – HealthDay

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.